Health Technology · Pharmaceuticals: Major · NSE: QUESTLAB · data 2026-10-09

Quest Laboratories Ltd.

Health check: Strong (8.1/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹102.9

Market cap

₹146 cr

P/E

11.2

P/B

1.7

ROE

16.7%

ROCE

19.3%

Debt / equity

0.08

Dividend yield

0.00%

1-year return

18.3%

52-week high

₹152.6

52-week low

₹68.6

Operating margin

15.6%

Growth

Revenue (last 12 months)	₹112 cr
Net profit (last 12 months)	₹15 cr
Sales growth, 3 years (yearly)	22.0%
Profit growth, 3 years (yearly)	43.4%

Similar companies

Curis Lifesciences Limited (CURIS) · Bal Pharma Limited (BALPHARMA) · Parnax Lab Limited (PARNAXLAB) · Krebs Biochemicals & Industries Ltd. (KREBSBIO) · Alpa Laboratories Limited (ALPA)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open QUESTLAB in NSE Scanner →